It is through the optimally coupled use of these two evolutionarily adaptive capacities—centrosome amplification and centrosome clustering—that cancer cells have the highest dividend and the transcription factor FOXM1 offers AR-low TNBC cells this critical capacity. Here, FOXM1 is linked to cancer.